BioDatomics Increases NGS Research Productivity with Launch of up to 100 Times Faster, More Intuitive Data Analysis Software

BETHESDA, Md. & BOSTON--(BUSINESS WIRE)--BioDatomics today introduced the company’s first commercial product, BioDT™, an open source suite of next generation sequencing (NGS) data analysis software and services. The new platform addresses the shortcomings found with current data analysis offerings by delivering much higher performance and an intuitive interface, thereby enabling genomic and biomedical researchers to more quickly glean meaningful insights from their data. The launch took place at the American Society of Human Genetics (ASHG) 2013 meeting in Boston, October 22-26.